IQVIA's second-quarter results exceeded expectations, with the company's strong backlog identified as a key factor behind its impressive performance.

IQVIA Holdings (IQV) saw its stock soar following a strong second-quarter performance and a positive outlook for revenue growth.

Several companies, including Boeing, Amkor, Corning, Sandisk, and Iqvia, are making headlines with significant stock movements during midday trading.

Several companies, including Franklin Electric, CTS Corporation, and Oshkosh, have reported better-than-expected earnings and revenue, leading many to raise or reaffirm their financial outlooks for fiscal year 2026.

Hardman Johnston Large Cap Equity continues to hold firm on its investment in IQVIA Holdings (IQV), citing specific reasons for its sustained confidence in the company. This reflects a strategic investment decision based on detailed analysis.

IQVIA's stock price has fallen, even though the company's underlying fundamentals remain strong.

IQVIA has conducted a review and analysis of the pharmaceutical market in Uzbekistan.

IQVIA Holdings Inc. is focusing on enhancing its clinical research and data capabilities as a strategy to drive future growth.

IQVIA Holdings (IQV) shares have rallied as investor concerns over biotech funding and clinical activity have begun to wane.

Analysts on Wall Street are presenting mixed views on the future performance of IQVIA Holdings stock, with some bullish and others bearish.

Reports detail various CEO and insider stock sales, including a Mueller CEO parting with shares after a significant run and an IQVIA CEO selling shares as bookings hit a record high. Additionally, Cathie Wood's sale of a surging tech stock is highlighted.

Costar projects its Q3 2026 adjusted EBITDA and revises its 2026 revenue, while IQVIA outlines its 2026 revenue and raises its adjusted EPS. Both companies provided their financial forecasts for the year 2026.

ICON plc shares have seen an increase after the company's deal with Anthropic and the release of Iqvia's earnings report.

An analysis explores whether IQVIA Holdings (IQV) demonstrates resilience amidst growing concerns surrounding artificial intelligence's impact on various sectors.

Morgan Stanley has revised its coverage of Contract Research Organizations (CROs), upgrading Charles River while downgrading IQVIA based on new assessments.

An analysis suggests that IQVIA Holdings (IQV) presents a compelling investment opportunity.

Financial analysts have released various insights and conflicting opinions on the performance and outlook of numerous companies across technology, healthcare, and financial sectors. These reports cover a range of firms, including Workday, IQVIA Holdings, and Gladstone Investment.

IQVIA has released the transcript from its first-quarter 2026 earnings call, detailing its financial results and business outlook.

IQVIA Holdings (IQV) saw its stock trade lower, attributed to investor fears surrounding artificial intelligence, despite the company reporting in-line financial results.

IQVIA (IQV) has launched its IQVIA.ai Unified Agentic AI Platform in collaboration with Nvidia, aiming to leverage advanced AI in healthcare and life sciences.

An assessment of whether IQVIA Holdings stock is underperforming the Nasdaq index.

Analysts at Mizuho have reiterated their bullish rating on IQVIA after the company released its fourth-quarter financial results.

IQVIA Holdings Inc. (IQV) is demonstrating impressive upside potential, even as it navigates threats linked to artificial intelligence.

Reports detail various CEO and insider stock sales, including a Mueller CEO parting with shares after a significant run and an IQVIA CEO selling $26.1 million in shares as bookings hit a record $3.15 billion. Additionally, Cathie Wood's sale of a surging tech stock is highlighted.

IQVIA Holdings Inc. and Amkor Technology, Inc. have both released their Q2 2026 earnings call summaries. These summaries provide insights into their financial performance for the second quarter of 2026.

IQVIA's stock has risen significantly after the company reported stronger-than-expected second-quarter results and increased its financial guidance.

An earnings preview outlines what to expect from IQVIA Holdings' financial report for the second quarter of 2026.

An analysis questions whether IQVIA Holdings stock is currently outperforming the Dow Jones Industrial Average.

Wall Street analysts are presenting mixed predictions regarding the future performance of IQVIA Holdings stock, with some forecasting a climb and others anticipating a decline. Investors are closely watching these analyses for guidance.

Investor Larry Robbins has reportedly increased his holdings and shown bullish sentiment towards several companies. His recent investments include Zillow Group, RH, IQVIA Holdings, DXC Technology, Myriad Genetics, Lithia Motors, and Global Payments.

An earnings preview has been released for IQVIA Holdings, detailing what to expect from the company's upcoming financial report.

TD Cowen has upgraded IQVIA (IQV) to a 'Buy' rating and increased its price target for the company's stock to $213.

Barclays has upgraded Medpace and IQVIA, stating that concerns regarding the impact of AI on these companies are exaggerated.

An analysis questions whether IQVIA Holdings Inc. (IQV) is a good investment after its recent earnings report.

Morgan Stanley has lowered its price target on IQVIA Holdings Inc. (IQV) to $240 but maintained an Overweight rating.